B Joseph Elmunzer1, Briana R Lewis1, Kristen F Miller2, Bethany J Wolf3, Lydia Zeiler4, David A Gutman4, Pooja Elias1, Aylin Tansel1, Robert A Moran1, Eric D Bolin4. 1. Division of Gastroenterology and Hepatology, Medical University of South Carolina, Charleston, SC, USA. 2. Department of Medicine, Medical University of South Carolina, Charleston, SC, USA. 3. Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA. 4. Department of Anesthesia and Perioperative Medicine, Medical University of South Carolina, Charleston, SC, USA.
Abstract
BACKGROUND: Excess post-operative opioid medication use can delay recovery and is associated with long-term misuse, addiction, and overdose. We aimed to explore the effect of pre-procedural thoracic paravertebral nerve block (PNB) on pain-related outcomes after POEM. METHODS: In this retrospective cohort study, consecutive patients who did and did not receive a PNB prior to POEM were compared. The outcomes were peak and cumulative pain scores, total opioid use during hospitalization, and length of stay. After adjusting for confounders, the associations between nerve block and the outcomes of interest were explored. RESULTS: Forty-nine consecutive patients were enrolled; 25 patients received a block whereas the subsequent 24 did not. There were no differences in baseline characteristics between the study groups. In unadjusted analyses, there was no significant difference between patients who did and did not undergo PNB in peak pain score (7.8 vs. 8.7, p=0.14), cumulative pain score in the first 12 hours (area under curve 66.5 vs. 75.8, p=0.22), median total opioid use (38.9 mg morphine equivalent dosing vs. 42, p=1.00), and median length of hospitalization (26.5 hours vs. 24, p=0.35). In multivariable regression models, PNB was not associated with a reduction in pain scores, opioid use, or hospitalization. There were no adverse events related to the block. CONCLUSIONS: In this exploratory, observational study, paravertebral nerve block immediately before POEM did not result in a statistically significant reduction in pain-related outcomes or hospitalization. Additional observational studies may elucidate whether higher anesthetic doses or longer acting formulations would be of value.
BACKGROUND: Excess post-operative opioid medication use can delay recovery and is associated with long-term misuse, addiction, and overdose. We aimed to explore the effect of pre-procedural thoracic paravertebral nerve block (PNB) on pain-related outcomes after POEM. METHODS: In this retrospective cohort study, consecutive patients who did and did not receive a PNB prior to POEM were compared. The outcomes were peak and cumulative pain scores, total opioid use during hospitalization, and length of stay. After adjusting for confounders, the associations between nerve block and the outcomes of interest were explored. RESULTS: Forty-nine consecutive patients were enrolled; 25 patients received a block whereas the subsequent 24 did not. There were no differences in baseline characteristics between the study groups. In unadjusted analyses, there was no significant difference between patients who did and did not undergo PNB in peak pain score (7.8 vs. 8.7, p=0.14), cumulative pain score in the first 12 hours (area under curve 66.5 vs. 75.8, p=0.22), median total opioid use (38.9 mg morphine equivalent dosing vs. 42, p=1.00), and median length of hospitalization (26.5 hours vs. 24, p=0.35). In multivariable regression models, PNB was not associated with a reduction in pain scores, opioid use, or hospitalization. There were no adverse events related to the block. CONCLUSIONS: In this exploratory, observational study, paravertebral nerve block immediately before POEM did not result in a statistically significant reduction in pain-related outcomes or hospitalization. Additional observational studies may elucidate whether higher anesthetic doses or longer acting formulations would be of value.
Authors: Salvatore Docimo; Abraham Mathew; Alexander J Shope; Joshua S Winder; Randy S Haluck; Eric M Pauli Journal: Surg Endosc Date: 2016-06-23 Impact factor: 4.584
Authors: Yuki B Werner; Daniel von Renteln; Tania Noder; Guido Schachschal; Ulrike W Denzer; Stefan Groth; Jan F Nast; Jan F Kersten; Martin Petzoldt; Gerhard Adam; Oliver Mann; Alessandro Repici; Cesare Hassan; Thomas Rösch Journal: Gastrointest Endosc Date: 2016-09-05 Impact factor: 9.427
Authors: Fraukje A Ponds; Paul Fockens; Aaltje Lei; Horst Neuhaus; Torsten Beyna; Jennis Kandler; Thomas Frieling; Philip W Y Chiu; Justin C Y Wu; Vivien W Y Wong; Guido Costamagna; Pietro Familiari; Peter J Kahrilas; John E Pandolfino; André J P M Smout; Albert J Bredenoord Journal: JAMA Date: 2019-07-09 Impact factor: 56.272
Authors: Yuki B Werner; Bengt Hakanson; Jan Martinek; Alessandro Repici; Burkhard H A von Rahden; Albert J Bredenoord; Raf Bisschops; Helmut Messmann; Marius C Vollberg; Tania Noder; Jan F Kersten; Oliver Mann; Jakob Izbicki; Alexander Pazdro; Uberto Fumagalli; Riccardo Rosati; Christoph-Thomas Germer; Marlies P Schijven; Alice Emmermann; Daniel von Renteln; Paul Fockens; Guy Boeckxstaens; Thomas Rösch Journal: N Engl J Med Date: 2019-12-05 Impact factor: 91.245
Authors: Shepard P Johnson; Kevin C Chung; Lin Zhong; Melissa J Shauver; Michael J Engelsbe; Chad Brummett; Jennifer F Waljee Journal: J Hand Surg Am Date: 2016-09-28 Impact factor: 2.230